April 2001
SinoMab was incorporated in Hong Kong
August 2010
Shenzhen SinoMab was established in Shenzhen, PRC.
February 2014
Hainan SinoMab was established in Haikou, PRC.
July 2018
SinoLink Pharma was established in Suzhou, PRC.
April 2019
Australia SinoMab was incorporated in Sydney, Australia.
June 2019
SinoMab was recognized as a “Principal Leading Project of the 13th Suzhou Industrial Park Science and Technology Leading Talents Appraisal” (蘇州工業園區第十三屆科技領軍人才重大領軍項目).
November 2019
Successfully listed on HKSE, became the first Hong Kong-based biopharmaceutical company listed on the Main Board
January 2020
Granted the Most Popular Newly Listed Company Award